Thomas W. Kenniston

909 total citations
15 papers, 694 citations indexed

About

Thomas W. Kenniston is a scholar working on Infectious Diseases, Molecular Biology and Genetics. According to data from OpenAlex, Thomas W. Kenniston has authored 15 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Thomas W. Kenniston's work include SARS-CoV-2 and COVID-19 Research (8 papers), Virus-based gene therapy research (3 papers) and Advancements in Transdermal Drug Delivery (3 papers). Thomas W. Kenniston is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), Virus-based gene therapy research (3 papers) and Advancements in Transdermal Drug Delivery (3 papers). Thomas W. Kenniston collaborates with scholars based in United States, Italy and Netherlands. Thomas W. Kenniston's co-authors include Andrea Gambotto, Shaohua Huang, Louis D. Falo, Géza Erdös, Eun Kim, Emrullah Korkmaz, Stephen C. Balmert, Cara Donahue Carey, Bart L. Haagmans and V. Stalin Raj and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and European Journal of Immunology.

In The Last Decade

Thomas W. Kenniston

14 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas W. Kenniston United States 8 278 228 170 152 84 15 694
Adel Benlahrech United Kingdom 13 94 0.3× 436 1.9× 140 0.8× 58 0.4× 39 0.5× 34 650
Jonas Söderholm Sweden 15 118 0.4× 315 1.4× 154 0.9× 118 0.8× 14 0.2× 28 965
Clare Primiero Australia 11 47 0.2× 136 0.6× 94 0.6× 246 1.6× 59 0.7× 32 540
Maria Hottelet Foley United States 5 174 0.6× 409 1.8× 226 1.3× 54 0.4× 19 0.2× 5 645
Andrés F. Vallejo United Kingdom 15 120 0.4× 166 0.7× 118 0.7× 20 0.1× 374 4.5× 39 742
Sebastian Ols Sweden 12 374 1.3× 399 1.8× 366 2.2× 16 0.1× 39 0.5× 20 867
Samuele Calabrό United States 10 129 0.5× 749 3.3× 260 1.5× 22 0.1× 30 0.4× 11 1.0k
Antonio Cosma France 22 300 1.1× 695 3.0× 423 2.5× 13 0.1× 44 0.5× 71 1.3k
Claudia C. Sombroek Netherlands 12 306 1.1× 617 2.7× 128 0.8× 13 0.1× 25 0.3× 16 857
Seishiro Naito Japan 15 56 0.2× 281 1.2× 183 1.1× 74 0.5× 16 0.2× 45 553

Countries citing papers authored by Thomas W. Kenniston

Since Specialization
Citations

This map shows the geographic impact of Thomas W. Kenniston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas W. Kenniston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas W. Kenniston more than expected).

Fields of papers citing papers by Thomas W. Kenniston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas W. Kenniston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas W. Kenniston. The network helps show where Thomas W. Kenniston may publish in the future.

Co-authorship network of co-authors of Thomas W. Kenniston

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas W. Kenniston. A scholar is included among the top collaborators of Thomas W. Kenniston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas W. Kenniston. Thomas W. Kenniston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Huang, Shaohua, Alessandro Ferrari, Donghoon Han, et al.. (2025). The Long-Term Immunity of a Microneedle Array Patch of a SARS-CoV-2 S1 Protein Subunit Vaccine Irradiated by Gamma Rays in Mice. Vaccines. 13(1). 86–86.
2.
Ferrari, Alessandro, Shaohua Huang, Donghoon Han, et al.. (2024). Fourth dose of microneedle array patch of SARS-CoV-2 S1 protein subunit vaccine elicits robust long-lasting humoral responses in mice. International Immunopharmacology. 129. 111569–111569. 3 indexed citations
3.
Hingrat, Quentin Le, Alessandro Ferrari, Josè Camilla Sammartino, et al.. (2023). Tetravalent SARS-CoV-2 S1 subunit protein vaccination elicits robust humoral and cellular immune responses in SIV-infected rhesus macaque controllers. mBio. 14(5). e0207023–e0207023. 2 indexed citations
4.
Kim, Eun Sun, et al.. (2023). Trivalent SARS-CoV-2 S1 Subunit Protein Vaccination Induces Broad Humoral Responses in BALB/c Mice. Vaccines. 11(2). 314–314. 6 indexed citations
5.
Ferrari, Alessandro, Shaohua Huang, Josè Camilla Sammartino, et al.. (2023). SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice. Microbiology Spectrum. 11(3). e0436322–e0436322. 5 indexed citations
6.
Kim, Eun Young, Alex McPherson, Florian Weisel, et al.. (2022). Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein. PubMed. 5(3). 177–191. 7 indexed citations
7.
Kim, Eun Ran, Florian Weisel, Stephen C. Balmert, et al.. (2021). A single subcutaneous or intranasal immunization with adenovirus‐based SARS‐CoV‐2 vaccine induces robust humoral and cellular immune responses in mice. European Journal of Immunology. 51(7). 1774–1784. 29 indexed citations
8.
Kim, Eun, Géza Erdös, Shaohua Huang, et al.. (2020). Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development. EBioMedicine. 55. 102743–102743. 310 indexed citations
9.
Guo, Zong Sheng, Zuqiang Liu, Magesh Sathaiah, et al.. (2017). Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus. Molecular Therapy — Methods & Clinical Development. 7. 112–122. 10 indexed citations
10.
Kim, Eun, Géza Erdös, Shaohua Huang, et al.. (2016). Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation. EBioMedicine. 13. 315–320. 87 indexed citations
11.
Gambotto, Andrea, Grzegorz Dworacki, Vito R. Cicinnati, et al.. (2000). Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Therapy. 7(23). 2036–2040. 146 indexed citations
12.
Appasamy, Pierette M., Thomas W. Kenniston, & Andrew A. Amoscato. (1997). Requirement for Surface Aminopeptidase Activities during Development of CD8+Fetal Thymocytes. Cellular Immunology. 177(1). 1–8. 2 indexed citations
13.
Kenniston, Thomas W., David J. Tweardy, Kevin F. Dyer, et al.. (1997). TCR-γ genes are rearranged but not transcribed in IL-7R α-deficient mice. The Journal of Immunology. 158(12). 5744–5750. 25 indexed citations
14.
Appasamy, Pierette M., et al.. (1995). Expression of diverse and functional TCR γ and Ig heavy chain transcripts in fetal liver cells cultured with interleukin-7. Molecular Immunology. 32(11). 805–817. 6 indexed citations
15.
Appasamy, Pierette M., Thomas W. Kenniston, Yan Weng, et al.. (1993). Interleukin 7-induced expression of specific T cell receptor gamma variable region genes in murine fetal liver cultures.. The Journal of Experimental Medicine. 178(6). 2201–2206. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026